AGEN•benzinga•June 3, 2025 at 11:08 AM

Agenus Inks Partnership Agreement With Zydus Lifesciences To Accelerate Clinical Development, Scale Global Manufacturing, And Expand Patient Access To Botensilimab And Balstilimab For Upfront Consideration Of $75M; Agenus To Receive Up To An Additional $5

No summary available.

Read the full article from the original source for complete details and context.

Article published on June 3, 2025 by benzinga